Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Merck gets Japanese nod for TEPMETKO(tepotinib) for non-small cell lung cancer

      Merck gets Japanese nod for TEPMETKO(tepotinib) for non-small cell lung cancer

      Medical Dialogues Bureau28 March 2020 11:45 AM IST
      TEPMETKO is the first regulatory approval globally for an oral MET inhibitor indicated for the treatment of advanced NSCLC harboring MET gene...
      Genentech,BARDA gets USFDA nod for Actemra Clinical Trial in COVID-19 patients

      Genentech,BARDA gets USFDA nod for Actemra Clinical Trial in COVID-19 patients

      Medical Dialogues Bureau28 March 2020 10:15 AM IST
      US: Genentech, a member of the Roche Group has announced the U.S. Food & Drug Administration (FDA) has approved a randomized, double-blind,...
      100 distilleries and more than 500 manufacturers permitted to produce hand sanitizers by Government

      100 distilleries and more than 500 manufacturers permitted to produce hand sanitizers by Government

      Medical Dialogues Bureau27 March 2020 1:35 PM IST
      Delhi: Central and State Governments are taking all steps to ensure the supply of essential items during the lockdown to combat the novel Coronavirus....
      Caplin Steriles gets USFDA approval for Verapamil Hydrochloride Injection

      Caplin Steriles gets USFDA approval for Verapamil Hydrochloride Injection

      Medical Dialogues Bureau27 March 2020 1:11 PM IST
      Verapamil Hydrochloride is a calcium channel blocker used in the treatment of cardiac conditions such as high blood pressure, arrhythmias, and angina.
      Hydroxychloroquine now a Prescription Drug: Health Ministry gazette puts it in Schedule H1 of DCA

      Hydroxychloroquine now a Prescription Drug: Health Ministry gazette puts it in Schedule H1 of DCA

      Medical Dialogues Bureau27 March 2020 1:07 PM IST
      New Delhi: Soon after banning the export of the Drug Hydroxychloroquine in light of the coronavirus, the government has now made the Drug into a...
      Cipla gets USFDA final nod for Esomeprazole ANDA for Oral Suspension

      Cipla gets USFDA final nod for Esomeprazole ANDA for Oral Suspension

      Medical Dialogues Bureau27 March 2020 12:51 PM IST
      Cipla's Esomeprazole for Oral Suspension 10mg, 20mg and 40mg is an AB-rated generic therapeutic equivalent version of AstraZeneca Pharmaceutical's ...
      Strides Pharma gets USFDA EIR for its Bangalore flagship facility

      Strides Pharma gets USFDA EIR for its Bangalore flagship facility

      Medical Dialogues Bureau27 March 2020 11:26 AM IST
      Bangalore: Strides Pharma has announced that the Company's flagship facility (KRS Gardens) in Bangalore which was inspected by the USFDA in March...
      Lupin appoints Ramesh Swaminathan as CFO, Head Corporate Affairs

      Lupin appoints Ramesh Swaminathan as CFO, Head Corporate Affairs

      Medical Dialogues Bureau27 March 2020 9:30 AM IST
      Mumbai: Pharma Major Lupin Limited (Lupin) announced the appointment of Ramesh Swaminathan as Chief Financial Officer and Head Corporate Affairs....
      Mylab ships first batch of COVID-19 test kits to government and private labs

      Mylab ships first batch of COVID-19 test kits to government and private labs

      Medical Dialogues Bureau26 March 2020 2:33 PM IST
      Pune: Pune-based molecular diagnostics company Mylab Discovery Solutions Pvt Ltd the developed first Made in India Covid-19 testing kit.Mylab has...
      Shortage of API: Bengal Chemicals can only supply only 10 lakh hydroxy-chloroquine

      Shortage of API: Bengal Chemicals can only supply only 10 lakh hydroxy-chloroquine

      Medical Dialogues Bureau26 March 2020 1:14 PM IST
      Kolkata: PSU pharma company Bengal Chemicals and Pharmaceuticals Ltd (BPCL) on Tuesday said it can provide only a maximum of 10 lakh...
      Beware of fake COVID-19 cyber cures warns EU medicines agency

      Beware of fake COVID-19 cyber cures warns EU medicines agency

      Medical Dialogues Bureau26 March 2020 12:29 PM IST
      The Hague: Europe's medicines agency Tuesday warned consumers not to buy any online medication claiming to be a treatment for COVID-19, saying doing...
      BAN on export of anti-malarial drug hydroxycloroquine with immediate effect: Govt

      BAN on export of anti-malarial drug hydroxycloroquine with immediate effect: Govt

      Medical Dialogues Bureau26 March 2020 12:27 PM IST
      "The export of hydroxycloroquine and formulations made from hydroxycloroquine is prohibited with immediate effect".
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok